Rob S. Sellar

2.1k total citations
22 papers, 482 citations indexed

About

Rob S. Sellar is a scholar working on Hematology, Genetics and Epidemiology. According to data from OpenAlex, Rob S. Sellar has authored 22 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Rob S. Sellar's work include Acute Myeloid Leukemia Research (8 papers), Cytomegalovirus and herpesvirus research (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rob S. Sellar is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Cytomegalovirus and herpesvirus research (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rob S. Sellar collaborates with scholars based in United Kingdom, United States and Denmark. Rob S. Sellar's co-authors include Karl S. Peggs, David C. Linch, Rosemary E. Gale, Benjamin L. Ebert, C. M. Evans, Christopher Allen, Robert K. Hills, J. Yin, Alan K. Burnett and Shaunt Fereshetian and has published in prestigious journals such as Circulation, Blood and The Journal of Pathology.

In The Last Decade

Rob S. Sellar

22 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob S. Sellar United Kingdom 11 300 154 135 96 91 22 482
Seiichiro Katagiri Japan 14 207 0.7× 199 1.3× 116 0.9× 49 0.5× 67 0.7× 59 498
Nahoko Nishimoto Japan 10 296 1.0× 216 1.4× 76 0.6× 46 0.5× 72 0.8× 13 476
Hirotoshi Sakaguchi Japan 13 442 1.5× 312 2.0× 204 1.5× 54 0.6× 65 0.7× 51 752
Ania Jankowska United States 7 369 1.2× 268 1.7× 160 1.2× 32 0.3× 45 0.5× 10 491
Daniela Gioia Italy 8 166 0.6× 207 1.3× 91 0.7× 50 0.5× 62 0.7× 19 415
Mateja Kralj Juric Austria 6 249 0.8× 102 0.7× 53 0.4× 85 0.9× 96 1.1× 7 454
F Beeldens Belgium 6 526 1.8× 297 1.9× 133 1.0× 65 0.7× 84 0.9× 11 642
Aining Sun China 16 562 1.9× 262 1.7× 149 1.1× 71 0.7× 170 1.9× 81 802
Árpád Bátai Hungary 13 253 0.8× 138 0.9× 152 1.1× 38 0.4× 61 0.7× 32 386
Noemi F. Pereira Brazil 13 264 0.9× 122 0.8× 81 0.6× 33 0.3× 91 1.0× 29 568

Countries citing papers authored by Rob S. Sellar

Since Specialization
Citations

This map shows the geographic impact of Rob S. Sellar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob S. Sellar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob S. Sellar more than expected).

Fields of papers citing papers by Rob S. Sellar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob S. Sellar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob S. Sellar. The network helps show where Rob S. Sellar may publish in the future.

Co-authorship network of co-authors of Rob S. Sellar

This figure shows the co-authorship network connecting the top 25 collaborators of Rob S. Sellar. A scholar is included among the top collaborators of Rob S. Sellar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob S. Sellar. Rob S. Sellar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molinaro, Roberto, Rob S. Sellar, Amélie Vromman, et al.. (2024). The clonal hematopoiesis mutation Jak2 aggravates endothelial injury and thrombosis in arteries with erosion-like intimas. International Journal of Cardiology. 409. 132184–132184. 17 indexed citations
2.
Sellar, Rob S., et al.. (2024). The emerging role of targeted protein degradation to treat and study cancer. The Journal of Pathology. 263(4-5). 403–417. 8 indexed citations
3.
Russell, Nigel H., Abin Thomas, Robert K. Hills, et al.. (2023). MRD Directed Treatment Intensification with Either FLAG-Ida or DA-Cladribine Improves Survival in Older AML Patients: Results from the NCRI AML18 Randomised Trial. Blood. 142(Supplement 1). 830–830. 4 indexed citations
4.
Vromman, Amélie, Shamsudheen Karuthedath Vellarikkal, Mariana Janini Gomes, et al.. (2020). Abstract 15355: Interleukin-1beta Inhibition Attenuates Accelerated Atherosclerosis in Mice With Tet2 Loss of Function in a Sex-dependent Fashion. Circulation. 142(Suppl_3). 1 indexed citations
5.
Sellar, Rob S., Clare Rowntree, Ajay Vora, et al.. (2018). Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003. British Journal of Haematology. 181(4). 515–522. 9 indexed citations
6.
Sellar, Rob S., Rosemary E. Gale, Asim Khwaja, et al.. (2018). Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome. British Journal of Haematology. 181(4). 486–494. 2 indexed citations
7.
Kahn, Josephine, Peter G. Miller, Alexander J. Silver, et al.. (2018). PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. 132(11). 1095–1105. 148 indexed citations
8.
Sellar, Rob S. & Julie-Aurore Losman. (2017). Targeting Aberrant Signaling in Myeloid Malignancies. Hematology/Oncology Clinics of North America. 31(4). 565–576. 3 indexed citations
9.
Green, Kile, Kim Pearce, Rob S. Sellar, et al.. (2017). Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts. Biology of Blood and Marrow Transplantation. 23(5). 805–812. 14 indexed citations
10.
Sellar, Rob S., Asim Khwaja, Rosemary E. Gale, et al.. (2016). Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment. British Journal of Haematology. 174(2). 275–279. 6 indexed citations
11.
Paul, Dirk S., Allison Jones, Rob S. Sellar, et al.. (2015). A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation. Genome Medicine. 7(1). 128–128. 6 indexed citations
12.
Sellar, Rob S. & Karl S. Peggs. (2014). Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update. Expert Opinion on Biological Therapy. 14(8). 1121–1126. 11 indexed citations
13.
Meja, Koremu, Chloe Stengel, Rob S. Sellar, et al.. (2014). PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways. British Journal of Haematology. 167(1). 69–79. 44 indexed citations
14.
Allen, Christopher, Robert K. Hills, C. M. Evans, et al.. (2013). The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. Leukemia. 27(9). 1891–1901. 96 indexed citations
15.
Sellar, Rob S. & Karl S. Peggs. (2012). The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation. Cytotherapy. 14(4). 391–400. 14 indexed citations
16.
Sellar, Rob S. & Karl S. Peggs. (2012). Therapeutic strategies for the prevention and treatment of cytomegalovirus infection. Expert Opinion on Biological Therapy. 12(9). 1161–1172. 24 indexed citations
17.
Sellar, Rob S. & Karl S. Peggs. (2012). Recent Progress in Managing Graft-Versus-Host Disease and Viral Infections Following Allogeneic Stem Cell Transplantation. Future Oncology. 8(12). 1549–1565. 10 indexed citations
18.
Sellar, Rob S., Anthony H. Goldstone, & Hillard M. Lazarus. (2011). Redefining Transplant in Acute Leukemia. Current Treatment Options in Oncology. 12(4). 312–328. 1 indexed citations
19.
Sellar, Rob S. & Karl S. Peggs. (2011). Management of multidrug‐resistant viruses in the immunocompromised host. British Journal of Haematology. 156(5). 559–572. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiichiro Katagiri Breakdown of academic impact, for papers by Nahoko Nishimoto Breakdown of academic impact, for papers by Hirotoshi Sakaguchi Breakdown of academic impact, for papers by Ania Jankowska Breakdown of academic impact, for papers by Daniela Gioia Breakdown of academic impact, for papers by Mateja Kralj Juric Breakdown of academic impact, for papers by F Beeldens Breakdown of academic impact, for papers by Aining Sun Breakdown of academic impact, for papers by Árpád Bátai Breakdown of academic impact, for papers by Noemi F. Pereira
Rankless by CCL
2026